Health
Albumedix enters into collaboration agreement with Cell and Gene Therapy Catapult – News-Medical.Net
Albumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered…
Albumedix Ltd. (‘Albumedix’), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
This agreement reflects the continued efforts of Albumedix to engage with the industry and expand upon its knowledge…
-
General23 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General22 hours agoJaguar Land Rover in UK pauses shipments to US
-
General20 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General18 hours agoAustralian share market set to dive as threat of US recession grows